ClearSign Technologies Corporation CLIR
3.45
(0.01)
(0.29%)
as of 25 Sep
- Market cap
- $23.6M
- P/E
- 0.0×
Follow CLIR
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
3.99 | 4.88 | 5.94 | 19.94 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(17.61) | (18.20) | (24.23) | (23.44) | |
P/B ratio |
2.21 | 3.22 | 3.26 | 4.73 | |
Price to Tangible BV |
2.39 | 3.58 | 3.54 | 5.17 | |
EV/Sales |
2.21 | 3.38 | 4.22 | 15.15 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(2.12) | (3.42) | (4.66) | (8.43) | |
EV/FCF |
(2.06) | (3.32) | (4.56) | (8.17) | |
Quick Ratio |
4.33 | 3.64 | 4.08 | 3.02 | |
Current Ratio |
4.78 | 4.05 | 4.34 | 3.28 | |
Net Debt/EBITDA |
6.96 | 3.53 | 12.12 | 6.24 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.41 | 0.41 | 0.37 | 0.14 | |
Operating CF/Net income |
0.95 | 0.62 | 4.13 | 1.28 | |
Capex/Depreciation |
(0.32) | (0.73) | (0.33) | (0.36) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
80.00% | 130.37% | 11.39% | 30.13% | |
Selling, General and Administrative Expense of Revenue |
228.21% | 857.07% | 33.04% | 175.70% | |
Intangible Assets out of Total Assets |
0.06 | 0.08 | 0.06 | 0.06 | |
Share Based Compensation of Revenue |
14.29% | 39.79% | 0.82% | 74.54% | |
Graham Net Nets |
0.41 | 0.27 | 0.28 | 0.19 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(26.21%) | (23.90%) | (18.79%) | (15.58%) | |
Free Cash Flow Yield |
(26.84%) | (20.82%) | (15.59%) | (9.31%) | |
Revenue per Share |
0.09 | 0.03 | 0.66 | 0.18 | |
Operating CF per Share |
(0.21) | (0.24) | (0.23) | (0.33) | |
Capex per Share |
0.00 | (0.01) | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.21) | (0.25) | (0.24) | (0.33) | |
Cash per Share |
1.67 | 1.37 | 1.65 | 1.88 | |
Shareholders Equity per Share |
1.66 | 1.35 | 1.72 | 1.63 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.66 | 1.35 | 1.72 | 1.63 | |
Free Cash Flow |
(1.26) | (1.41) | (1.31) | (1.86) | |
Working Capital |
8.85 | 6.61 | 8.64 | 8.17 | |
Capital Expenditures |
(0.02) | (0.06) | (0.02) | (0.02) | |
Net Current Asset Value |
8.83 | 6.57 | 8.58 | 8.08 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.04 | 0.34 | 0.01 | 0.02 | |
Net Profit Margin |
(233.39%) | (1,146.60%) | (8.47%) | (138.87%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.13 | 0.15 | 0.76 | 0.54 | |
Average Payables |
1.50 | 1.46 | 1.43 | 1.73 | |
Average Assets |
13.21 | 12.19 | 14.23 | 14.92 | |
Average Common Equity |
10.12 | 9.83 | 11.65 | 11.95 |
Columns are period end dates